GWLLOTCFood and Kindred ProductsFiscal year ends December 31
GOLDENWELL BIOTECH, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026
- Market cap
- $64.35M
- P/E (TTM)
- –
- Dividend yield
- –
Goldenwell Biotech statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Food and Kindred Products companies for comparison
Valuation
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Market Cap | $64.35M | $523.73M |
| Enterprise Value | $64.34M | $678.11M |
| PS Ratio | 1170000.00 | 0.88 |
Enterprise value
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| EV / Sales | 1169800.00 | 1.19 |
Income (trailing twelve months)
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Revenue | $55 | $862.46M |
| Gross Profit | $12 | $228.35M |
| Operating Income | -$114.80K | $303.56K |
| Net Income | -$282.12K | $987.94K |
| EBITDA | -$114.80K | $9.49M |
| EPS (Diluted) | $0.00 | $0.14 |
Margins
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Gross Margin | 21.8% | 29.2% |
| Operating Margin | -208729.0% | 3.19% |
| Profit Margin | -512940.0% | 1.22% |
| EBITDA Margin | -208729.0% | 5.97% |
Returns
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Return on Assets (ROA) | -190.4% | 1.11% |
Growth
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | -89.5% | 1.96% |
Balance sheet
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $11.14K | $42.94M |
| Net Cash (Debt) | $11.14K | -$3.87M |
| Net Cash Per Share | $0.00 | -$0.06 |
| Equity (Book Value) | -$398.20K | $154.80M |
| Book Value Per Share | -$0.00 | $5.60 |
| Tangible Book Value | -$398.20K | $21.64M |
Financial position
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Quick Ratio | 0.11 | 0.52 |
Cash flow (trailing twelve months)
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Operating Cash Flow | -$110.37K | $21.97M |
Efficiency
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.91 |
| Inventory Turnover | 0.00 | 5.37 |
Dividends and yields
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Earnings Yield | -0.44% | 1.40% |
Shares
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Shares Outstanding | 99,000,000 | 76,208,500 |
| Shares Change (YoY) | 0.00% | 0.42% |
| Shares Change (QoQ) | 0.00% | 0.02% |
| Float | 79,000,000 | 55,899,400 |
| Shares Held by Insiders | 20.2% | 10.2% |
Taxes
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Income Tax | $0 | $9.75M |
Scores
| Measure | Goldenwell Biotech | Industry median |
|---|---|---|
| Altman Z-Score | -5.33 | 1.51 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Goldenwell Biotech's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.